GPX4 and cancer: In summary, our research has revealed a novel mechanism in which gankyrin increases the expression of SLC7A11 and GPX4 through p53 ubiquitination, thus hindering ferroptosis-induced cell death in TNBC and potentially facilitating cancer cell survival.